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Abstract
 
The intracellular pathogen 
 
Brucella
 
 is the causative agent of brucellosis, a worldwide zoonosis
that affects mammals, including humans. Essential to 
 
Brucella
 
 virulence is its ability to survive and
replicate inside host macrophages, yet the underlying mechanisms and the nature of the replica-
tive compartment remain unclear. Here we show in a model of 
 
Brucella
 
 
 
abortus
 
 infection of mu-
rine bone marrow–derived macrophages that a fraction of the bacteria that survive an initial
macrophage killing proceed to replicate in a compartment segregated from the endocytic path-
way. The maturation of the 
 
Brucella
 
-containing vacuole involves sustained interactions and fusion
with the endoplasmic reticulum (ER), which creates a replicative compartment with ER-like
properties. The acquisition of ER membranes by replicating 
 
Brucella
 
 is independent of ER-Golgi
COPI-dependent vesicular transport. A mutant of the VirB type IV secretion system, which is
necessary for intracellular survival, was unable to sustain interactions and fuse with the ER, and
was killed via eventual fusion with lysosomes. Thus, we demonstrate that live intracellular 
 
Bru-
cella
 
 evade macrophage killing through VirB-dependent sustained interactions with the ER.
Moreover, we assign an intracellular function to the VirB system, as being required for late mat-
uration events necessary for the biogenesis of an ER-derived replicative organelle.
Key words: macrophage • 
 
Brucella
 
 • endoplasmic reticulum • type IV secretion • trafﬁcking
 
Introduction
 
Pathogenic bacteria have evolved various strategies to
counteract host defense mechanisms to create a safe niche
of replication inside the host. In mammals, this involves
surviving innate components of the immune response, such
as killing by professional phagocytes. For instance, intracel-
lular bacterial pathogens are capable of avoiding degradation
along the endocytic pathway through various means (for
review see reference 1), many mechanisms of which are yet
to be understood.
Several of the microorganisms comprising the 
 
 
 
-2 sub-
group of proteobacteria have coevolved with their eukary-
otic hosts, including bacteria of the genus 
 
Brucella
 
. Others
include the plant pathogen 
 
Agrobacterium tumefaciens
 
, the
plant symbiont 
 
Rhizobium meliloti
 
, and the intracellular ani-
mal pathogens 
 
Bartonella
 
 spp. and 
 
Rickettsia
 
 spp. (2). 
 
Brucella
 
is the causative agent of brucellosis, a worldwide zoonosis
that affects a broad range of mammals, including livestock
and humans (3). Human brucellosis is a chronic, debilitat-
ing disease with severe, and sometimes fatal, outcome (3).
 
Brucella
 
 is considered a facultatively extracellular, intracellu-
lar pathogen that survives and replicates inside both phago-
cytic and nonphagocytic host cells (4). Intracellular survival
and replication are key virulence features of 
 
Brucella 
 
be-
cause mutants defective for these attributes are also aviru-
lent (5, 6). In infected hosts, 
 
Brucella
 
 resides in tissues of the
reticuloendothelial system and survives intracellularly
within macrophages, a feature essential to the establishment,
development, and chronicity of the disease. However, the
underlying molecular mechanisms of the bacteria’s interac-
tion with macrophages remain unclear.
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Abbreviations used in this paper:
 
 BCV, 
 
Brucella
 
-containing vacuole; BFA,
brefeldin A; BMDM, bone marrow–derived macrophages; CI-M6PR,
cation-independent mannose-6-phosphate receptor; EM, electron mi-
croscopy; G6Pase, glucose-6-phosphatase; GFP, green fluorescent pro-
tein; LAMP-1, lysosomal-associated membrane glycoprotein 1; MDC,
monodansylcadaverine.T
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Brucella
 
 Survival within Macrophages
 
It has been proposed, and partially demonstrated, that
 
Brucella
 
 intracellular survival in macrophages results from an
inhibition of fusion between the 
 
Brucella
 
-containing vacu-
ole (BCV) and lysosomes, through alteration of BCV mat-
uration along the endocytic pathway (7, 8). Yet, the nature
of the 
 
Brucella
 
 replicative compartment in macrophages is
controversial (4). It has been suggested that 
 
Brucella
 
 repli-
cate inside compartments with phagolysosomal characteris-
tics (7), but this would imply a completed process of
phagosome maturation, which contradicts with the inhibi-
tion of BCV fusion with lysosomes.
In HeLa cells, 
 
Brucella abortus
 
 and 
 
Brucella melitensis
 
 pre-
vent lysosome fusion by escaping from the endocytic path-
way before interacting with late endosomes. They transit
through an intermediate vacuole with autophagic features,
and ultimately replicate in a compartment characterized by
the presence of ER markers (9–11). Consistently, early ul-
trastructural observations in Vero cells, or trophoblasts from
infected pregnant goats, have shown the presence of 
 
Bru-
cella
 
 spp. replicating in the ER (12, 13).
Attempts by several laboratories to identify bacterial ge-
netic determinants involved in 
 
Brucella
 
 virulence recur-
rently led to the identification of the 
 
virB
 
 locus (5, 6, 11,
14–16). This region is homologous to the 
 
virB
 
 operon of
 
A. tumefaciens
 
, which encodes a type IV secretion system
(14). Such machineries are dedicated to the secretion or ex-
port of nucleoprotein complexes or proteins, and many op-
erate in pathogenic bacteria, such as 
 
A. tumefaciens
 
, 
 
Borde-
tella pertussis
 
, 
 
Helicobacter pylori
 
, or the intracellular pathogen
 
Legionella pneumophila
 
 (17). Various 
 
Brucella
 
 
 
virB
 
 mutants are
avirulent in a mouse model (5, 6, 16) and a functional VirB
system is required for establishing and maintaining a persis-
tent infection (5). Furthermore, this locus is required for
intracellular survival in macrophages and HeLa cells (11,
14–16). Recent evidence suggests that the VirB system is
involved in controlling the maturation of BCV into an or-
ganelle permissive for replication (11, 18). Thus, the cur-
rent hypothesis is that VirB mediates translocation of bacte-
rial effector molecule(s) into the host cell that controls
BCV maturation (11, 18, 19). However, no VirB effector
has been identified to date and the stage(s) of BCV matura-
tion controlled by VirB is yet to be resolved.
Here we have performed a detailed analysis of 
 
B. abortus
 
intracellular fate within murine bone marrow–derived
macrophages (BMDM) to precisely define the nature, and
understand the biogenesis of, the 
 
Brucella
 
 replicative com-
partment in professional phagocytes. In addition, we have
also further defined the role of the VirB type IV secretion
system in BCV maturation in macrophages. Our results
clearly establish the essential role of the BCV
 
 
 
interactions
with the macrophage ER in bacterial intracellular survival.
 
Materials and Methods
 
Bacterial Strains.
 
The bacterial strains used in this study were
the smooth virulent 
 
B. abortus
 
 strain 2308 (9) and an isogenic
nonpolar mutant of the 
 
virB10
 
 gene (16). Green fluorescent pro-
tein (GFP)-expressing derivatives were made by electroporating
both strains with a pBBR1MCS-2 derivative (20) expressing the
 
gfp-mut3
 
 gene under the control of the 
 
lac
 
 promoter. Bacteria
were grown in tryptic soy broth (TSB; Sigma-Aldrich) and kept
frozen at 
 
 
 
80
 
 
 
C in 15% glycerol-TSB medium. For infection, 2
ml TSB were inoculated with a single bacterial colony from a
freshly streaked TSB agar plate and grown at 37
 
 
 
C for 15 h (early
stationary phase) up to an optical density (OD
 
600nm
 
) of 
 
 
 
2.0. In
these growth conditions, the VirB type IV secretion system was
expressed (unpublished data).
 
Antibodies and Reagents.
 
The primary antibodies used were:
rabbit polyclonal anti–cation-independent mannose-6-phosphate
receptor (CI-M6PR; 9); anti-Rab7 (21); anti–lysosomal-associ-
ated membrane glycoprotein 1 (LAMP-1; 22); anti–human
cathepsin D (DakoCytomation); anti-calnexin (StressGen Bio-
technologies); anti–human calreticulin (Affinity BioReagents,
Inc.); anti-sec61
 
  
 
(9); rat anti–mouse LAMP-1 monoclonal anti-
body 1D4B (Developmental Studies Hybridoma Bank, National
Institute of Child Health and Human Development, National In-
stitutes of Health, University of Iowa); goat polyclonal anti–
human EEA-1 (Santa Cruz Biotechnology, Inc.); and cow poly-
clonal anti–smooth 
 
B. abortus
 
 2308 (9). The secondary antibodies
used were: Alexa Fluor
 
® 
 
488–conjugated goat anti–cow, Alexa
Fluor
 
® 
 
594–conjugated goat anti–rabbit, and Alexa Fluor
 
® 
 
594–
conjugated donkey anti–goat IgG (Molecular Probes); and cya-
nin-5–conjugated donkey anti–rat (Jackson ImmunoResearch
Laboratories). The fluorescent probe monodansylcadaverine
(MDC; Sigma-Aldrich) was used to label autophagic compart-
ments by incubating infected cells with 0.05 mM MDC in the
culture medium for 30 min before processing for immunofluo-
rescence. Proaerolysin was provided by G. van der Goot (Uni-
versity of Geneva, Geneva, Switzerland) and was used on in-
fected cells at a concentration of 0.5 nM for the indicated time.
Brefeldin A (BFA; Sigma-Aldrich) was used at a final concentra-
tion of 10 
 
 
 
g/ml.
 
BMDM Culture and Infection.
 
Bone marrow cells were iso-
lated from femurs of 6–10-wk-old C57Bl/6 female mice and dif-
ferentiated into macrophages as previously described (23). Infec-
tions were performed at a multiplicity of infection of 50:1 by
centrifuging bacteria onto macrophages at 400 
 
g 
 
for 10 min at
4
 
 
 
C, and then incubating the cells for 15 min at 37
 
 
 
C under 7%
CO
 
2 
 
atmosphere. Macrophages were extensively washed with
DMEM to remove extracellular bacteria and incubated for an ad-
ditional 90 min in medium supplemented with either 100 
 
 
 
g/ml
gentamicin (strain 2308) or 100 
 
 
 
g/ml streptomycin (strain
 
virB10
 
) to kill extracellular bacteria. Thereafter, the antibiotic
concentrations were decreased to 10 
 
 
 
g/ml. At each time point,
samples were washed three times with PBS before processing. To
monitor 
 
Brucella
 
 intracellular survival, infected cells were lysed
with 0.1% (vol/vol) Triton X-100 in H
 
2
 
O after PBS washing and
serial dilutions of lysates were rapidly plated onto TSB agar plates
to enumerate CFUs.
 
Immunofluorescence Microscopy.
 
Macrophages were fixed with
3% paraformaldehyde, pH 7.4, at 37
 
 
 
C for 10 min, and then pro-
cessed for immunofluorescence staining as previously described
(9). Specimens were observed either on a Leica DMRBE epiflu-
orescence microscope for quantitative analysis, or a Zeiss LSM
510 laser scanning confocal microscope for image acquisition.
Images of 1,024 
 
  
 
1,024 pixels were acquired and assembled us-
ing Adobe Photoshop 7.0.
 
Transmission Electron Microscopy (EM).
 
Macrophages were pro-
cessed as previously described (23). The detection of glucose-
6-phosphatase (G6Pase) activity was performed by EM cytochem-
istry as previously described (24) with minor modifications.T
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Cells were prefixed in 1.25% (vol/vol) glutaraldehyde in 0.1 M
Pipes, pH 7.0, containing 5% (wt/vol) sucrose for 30 min on
ice, washed three times for 3 min in 0.1 M Pipes, pH 7.0, con-
taining 10% (wt/vol) sucrose, and then briefly in 0.08 M Tris-
maleate buffer, pH 6.5. Cells were incubated in 0.06 M glu-
cose-6-phosphate (Sigma-Aldrich), 0.1% lead nitrate (wt/vol) in
0.08 M Tris-maleate, pH 6.5, for 2 h at 37
 
 
 
C. After three washes
in 0.08 M Tris-maleate buffer for 2 min and three washes in
0.1 M cacodylate buffer, pH 7.2, containing 0.1 M sucrose, 5 mM
CaCl
 
2
 
, and 5 mM MgCl
 
2
 
, cells were postfixed in 1.25% (vol/vol)
glutaraldehyde in the same buffer for 1 h at 4
 
 
 
C, and then with
1% OsO
 
4 
 
in the same buffer devoid of sucrose for 1 h at room
temperature. Samples were then further processed as previously
described (23).
 
Results
 
Survival and Replication of B. abortus inside Murine BMDM.
 
We first monitored the survival and replication of both
the wild-type 2308 and the 
 
virB10
 
 mutant strains by
evaluating the number of CFUs retrieved from infected
primary cultures of murine BMDM at different times after
infection. When macrophages were infected with the wild-
type strain, 
 
 
 
90% of the ingested bacteria were rapidly
killed by macrophages (Fig. 1 A) because a decrease of one
order of magnitude in the number of intracellular live 
 
Bru-
cella
 
 occurred within the first 4 h of infection (Fig. 1 A).
Thereafter, some of the surviving wild-type 
 
Brucella
 
 were
capable of replication as indicated by an increase in the
number of intracellular bacteria after 4 h after infection
(Fig. 1 A). When analyzing the fate of a 
 
virB10
 
 mutant
strain, a decrease of intracellular live bacteria comparable to
that of the wild-type strain was observed until 4 h after in-
fection (Fig. 1 A), indicating that a functional VirB system
is not required for the short-term survival of 
 
Brucella
 
 inside
macrophages. At later time points, the number of live
 
virB10
 
 mutants progressively decreased. Hence, the 
 
Brucella
virB10
 
 strain did not replicate, but rather was killed. To
better define this time course of events, we monitored the
overall levels of macrophage infection by scoring the num-
ber of intracellular bacteria for 2308- or 
 
virB10
 
-infected
BMDM. At 2 h after infection, for both strains the majority
of BMDM contained less than five bacteria and the infec-
tion levels were similar (Fig. 1 B). By 8 h after infection,
for both strains the percentage of BMDM with less than
five bacteria decreased, whereas the number of uninfected
macrophages significantly increased (Fig. 1 B). Thus, by 8 h
after infection some macrophages cleared 
 
Brucella
 
, consis-
tent with CFU counts (Fig. 1 A). By 24 h after infection,
15.0 
 
  
 
6.1% of 2308-infected BMDM contained 
 
 
 
10 bac-
teria, demonstrating that bacterial replication had occurred,
but only within a limited number of macrophages. In con-
trast, no replication was observed for 
 
virB10
 
 bacteria. Strik-
ingly, the majority of the macrophage population at 24 h
after infection was devoid of bacteria, for both 2308 and
 
virB10
 
 infections (Fig. 1 B), demonstrating a continuous
killing of intracellular 
 
Brucella
 
 after 4 h of infection To con-
firm this, we analyzed by immunofluorescence the fusion
events between BCVs and lysosomes by monitoring the
colocalization of bacteria with the lysosomal luminal hy-
drolase cathepsin D (Fig. 1 C). Until 4 h after infection, a
similar percentage of 2308- and 
 
virB10
 
-containing vacuoles
were cathepsin D
 
  
 
(Fig. 1 C), demonstrating some fusion
of wild-type and 
 
virB10
 
 phagosomes with lysosomes at
early stages of the infection. These results are consistent
with the decreased number of intracellular bacteria ob-
served for both strains over this time frame (Fig. 1 A). After
4 h of infection, coincident with the onset of bacterial rep-
lication, the percentage of cathepsin D
 
  
 
2308-containing
vacuoles decreased (Fig. 1 C). By contrast, the percentage
of cathepsin D
 
  
 
virB10
 
-containing vacuoles significantly
increased with time (Fig. 1 C), consistent with bacterial
killing as assessed by CFU counting (Fig. 1 A). Indeed, the
majority of wild-type 
 
Brucella
 
 did not colocalize with ca-
Figure 1. Survival and replication of Brucella strains within BMDM.
BMDM were infected with either the wild-type 2308 or the virB10 mu-
tant Brucella strains for various times. CFUs were enumerated after lysis
(A) or samples were fixed and processed for immunofluorescence (B–D).
(A) Representative growth curves of wild-type 2308 ( ) and virB10 ( )
strains inside BMDM. (B) Quantitation of 2308- or virB10-infected
BMDM containing either no bacteria (open bars), less than five bacteria
(light gray bars), between 5 and 10 bacteria (dark gray bars), or  10 bac-
teria (solid bars) at 2, 8, and 24 h after infection. Data are means   SD of
three independent experiments. (C) Quantitation of cathepsin D acquisi-
tion by BCVs. Data are means   SD of three independent experiments.
(D) Representative confocal images showing colocalization of Brucella
with cathepsin D in BMDM infected with either the wild-type 2308 or
the virB10 mutant Brucella strains for 24 h. Arrows indicate colocalization
and arrowheads show cathepsin D  BCVs. Bar, 5  m.T
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thepsin D at 24 h after infection, whereas most of the
virB10-containing vacuoles were cathepsin D  (Fig. 1 D).
This indicates that although the virB10 mutants are capable
of short-term survival, they cannot evade long-term degra-
dation through fusion with lysosomes. Taken together,
these results show that a fraction of intracellular Brucella that
survive the initial macrophage killing are capable of further
survival and replication, via a VirB-dependent prolonged
evasion of fusion with lysosomes.
Replicating BCVs Do Not Interact with Late Endocytic Com-
partments. Next, we focused on defining the nature of the
Brucella replicating compartment in macrophages. During
our initial experiments, we observed that one (by 24 h after
infection) to two thirds (by 48 h after infection) of the in-
tracellular Brucella (detected by either 4 ,6 -diamino-2-phe-
nylindole or GFP expression) were not labeled by various
Brucella-specific antisera (unpublished data), suggesting that
significant surface changes on intracellular Brucella occur
during replication. To overcome the shortcomings of the
antisera staining and ensure we were analyzing the majority
of the intracellular bacteria, we used GFP-expressing Bru-
cella strains. Intramacrophagic GFP expression correlated
well with intact bacteria because only a small fraction (10%
at 4 h after infection and 13% at 24 h after infection) of in-
tracellular GFP-2308 were accessible to propidium iodide
staining after in vivo saponin permeabilization of macro-
phage membranes (unpublished data). Thus, we examined the
BCV trafficking in BMDM by immunofluorescence. 5 min
after entry, Brucella were found in compartments positive
for the early endosomal antigen 1 EEA-1 (Fig. 2 A), indi-
cating that early BCVs interact with early endosomes. This
interaction was very transient because little to no colocal-
ization was detected by 30 min after infection (Fig. 2 A).
Concurrent with this decrease, a rapid acquisition of
LAMP-1 was observed (Fig. 2 A) and the majority of BCVs
remained LAMP-1  until 4 h after infection (Fig. 2 C). Lit-
tle to no colocalization with either the Rab7 GTPase, CI-
M6PR, or cathepsin D was detected at the same time
points, suggesting that LAMP-1 found on BCVs did not
originate from interactions with late endosomes (Fig. 2 C).
At times later than 4 h after infection, the percentage of
LAMP-1  BCVs progressively decreased to 9.7   1.2% at
24 h after infection (Fig. 2, B and C), whereas no colocal-
ization of Brucella with Rab7, CI-M6PR, or cathepsin D
was detected (Fig. 2, B and C). Taken together, these re-
sults demonstrate that live Brucella interact with early but
not late compartments of the endocytic pathway in primary
macrophages, which excludes a late endosomal nature of
the Brucella replicative compartment.
BCVs Do Not Interact with Autophagic Compartments in
Macrophages. In epithelial cells, the autophagic pathway
has been identified as an intermediate of Brucella intracellu-
lar trafficking (9, 10). By contrast, no significant colocaliza-
tion of GFP Brucella with organelles positive for the au-
tophageous probe MDC (25) in BMDM was observed at
any time point examined (Fig. 2 D). Furthermore, all the
MDC  BCVs scored (a maximum of 10.3   4.0% at 30
min after infection) contained bacteria with barely detect-
able levels of GFP expression (not depicted), hence likely
degraded. Thus, Brucella do not seem to interact with au-
tophagic compartments in BMDM, which was also previ-
ously described for J774 macrophage-like cells (7).
BCVs Acquire ER Markers during Maturation into a Replica-
tive Organelle. Given the interactions of intracellular Bru-
cella with the ER of tissue culture epithelial cells (9, 11, 13)
and trophoblasts from infected animals (12), we sought to
determine whether such interactions also occurred in
BMDM. Therefore, we analyzed the presence of specific
markers of the ER on BCVs at various time points after in-
fection, using immunofluorescence microscopy. A signifi-
cant number of BCVs (a maximum of 35.7   3.5% at 20
min after infection) were surrounded by ER  structures as
early as 10 min after entry (Fig. 3 B, inset), as described re-
cently for phagocytosis of latex beads and some microbial
pathogens (26). Thereafter, the number of calnexin  BCVs
slightly decreased and then increased again by 4 h after in-
Figure 2. Live Brucella interact with early but not late endocytic com-
partments. BMDM were infected with the GFP-expressing Brucella wild-
type strain GFP-2308 for various times. Samples were fixed and processed
for immunofluorescence. (A) Confocal images and quantitation of EEA-1
or LAMP-1 acquisition by early BCVs. Arrowheads show intracellular
Brucella within either EEA-1  or LAMP-1  vacuoles. Data are means  
SD of three independent experiments. (B) Confocal images of GFP-
2308–infected BMDM at 24 h after infection. Replicating Brucella do not
colocalize with either CI-M6PR, LAMP-1, or cathepsin D. (C) Quanti-
tation of LAMP-1, Rab7, CI-M6PR, and cathepsin D acquisition by
BCVs during maturation. Data are means   SD of three to five indepen-
dent experiments. (D) Quantitation of MDC accumulation within BCVs.
Data are means   SD of three independent experiments. Bars, 2  m (A)
and 10  m (B).T
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fection whereby 37.7   6.7% of BCVs were positive (Fig.
3, A and B), suggesting sequential interactions with the ER.
At later time points, such as 12 h after infection, 66.0  
6.0% of Brucella were tightly surrounded by calnexin label-
ing in a pattern different from earlier time points, which
suggested a staining of the BCV itself (Fig. 3 A). By 24 h af-
ter infection, 91.0   6.2% of BCVs were positive for cal-
nexin (Fig. 3, A and B). Similar patterns were obtained
when detecting the ER chaperone calreticulin or the trans-
locator Sec61   (not depicted). The biphasic interactions
observed do suggest that the early and late colocalizations of
ER markers with BCVs are independent events. Addition-
ally, these results indicate that BCVs interact with the ER
during their maturation and acquire ER markers concomi-
tantly with the biogenesis of the replicative compartment.
To test whether Brucella recruit ER membranes to their
vacuole during maturation, we examined the ER structure
of infected macrophages at 48 h after infection, when an
extensive replication of Brucella has occurred. Compared
with uninfected macrophages, Brucella-infected cells showed
a dramatic reorganization of the ER, which was con-
strained to the bacterial replication area. No detectable ER
structures were observed elsewhere in the infected cells
(Fig. 3 C). This strongly suggests that the extensive replica-
tion of Brucella is linked to an accretion of ER, which
could originate from ER membrane acquisition during
BCV maturation.
Intermediate BCVs Harbor both LAMP-1 and ER Mark-
ers. Given the striking presence of LAMP-1 on maturing
BCVs (Fig. 2), we next assessed whether these LAMP-1 
BCVs acquire ER markers by examining the presence of
both markers on bacterial vacuoles by confocal microscopy.
During the first 4 h after infection, the majority of BCVs
were positive only for LAMP-1 (Fig. 4 A). This population
decreased thereafter to only 4.6   2.3% of BCVs at 24 h
after infection, indicating this LAMP-1  BCV population is
not persistent (Fig. 4 A) and corresponds to vacuoles that
mature into either degradative or replicative compartments,
hence either disappear or acquire ER markers. Interest-
ingly, calnexin /LAMP-1  BCVs could be detected dur-
ing the first 12 h after infection (Fig. 4 B), with the peak
between 2 and 8 h after infection (28.4   3.2% at 4 h after
infection; Fig. 4 A). Nearly one third of the BCVs har-
bored both LAMP-1 and calnexin at times up to 8 h after
infection, which demonstrates that a significant population
of LAMP-1  BCVs interacted with the ER (Fig. 4 B). Fur-
thermore,  10% of BCVs were only positive for calnexin
at 2 and 4 h after infection. This demonstrates that most
calnexin  BCVs detected up to 4 h after infection (Fig. 3
B) are also LAMP-1  (Fig. 4 A), strongly suggesting these
BCVs originate as LAMP-1  vacuoles. At times later than
8 h after infection, the percentage of LAMP-1 /calnexin 
vacuoles decreased, whereas that of calnexin  BCVs pro-
gressively increased (41.9   7.5% at 12 h after infection
and 87.7   2.0% at 24 h after infection; Fig. 4, A and B).
Taken together, these results demonstrate the occurrence
of an early population of LAMP-1 /calnexin   BCVs,
Figure 3. BCVs acquire ER markers during maturation. BMDM were
infected with the GFP-expressing Brucella wild-type strain GFP-2308 for
various times. Samples were fixed and processed for immunofluorescence.
(A) Representative confocal images of a time course of GFP–Brucella in-
teraction with ER structures. Arrowheads indicate calnexin  BCVs. (B)
Quantitation of BCV association with, and acquisition of, calnexin 
structures. Data are means   SD of five independent experiments. (C)
Overimposed confocal and differential interference contrast (DIC) images
of BMDM infected with GFP Brucella for 48 h. The ER was labeled using
rabbit anti–calreticulin, followed by Alexa Fluor® 594–conjugated goat
anti–rabbit antibodies. The arrow indicates a Brucella-infected BMDM,
whose ER is reorganized into or around BCVs. Bars, 5  m (A), 1  m (A
insets), 20  m (C), and 2  m (C inset).T
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which precedes the appearance of calnexin  only vacuoles.
Thus, BCV maturation is evidenced by an intermediate
population of bacterial vacuoles that can mature into
calnexin  replicative compartments through the exclusion
of LAMP-1, possibly by recycling LAMP-1  membranes
while interacting with the ER.
BCVs Interact with the ER to Exchange Membranes during
Maturation. To address the possible acquisition of ER
membranes by BCVs, we performed an ultrastructural
analysis of the immediate environment of BCVs by EM.
BCVs were found closely associated with some ER struc-
tures as early as 4 h after infection (Fig. 5 A). At 24 h after
infection, replicating BCVs were surrounded by ER (Fig. 5
B), demonstrating a sustained association with this or-
ganelle. Of particular interest, these vacuoles were locally
studded with ribosomes (Fig. 5 C) and intimate points of
contact with the ER were detected (Fig. 5 D). This
strongly suggested the occurrence of membrane exchange
between BCVs and the ER. To confirm this, we examined
the presence of the ER-specific G6Pase on BCVs, as a
marker of BCV–ER fusion. At early time points (30 min
after infection), no G6Pase was detected either inside or
close to most BCVs (Fig. 5 E). By 2 h after infection, BCV
contacted G6Pase  structures and this was more accentu-
ated at 4 h after infection (Fig. 5, F and G). However, no
G6Pase was detected inside BCVs at these stages, showing
that no major fusion events between BCV and ER had oc-
curred. By contrast, at 24 h after infection, most BCVs
were G6Pase  (Fig. 5 H), and some were indeed found fus-
ing with the ER (Fig. 5 I). Such results explain the differ-
ent patterns of ER staining around or on the BCVs ob-
served by immunofluorescence at early and late times after
infection as sequential interaction events with the ER (Fig.
3 A). Together with our previous results, this clearly dem-
onstrates that BCVs are capable of sustained interactions
with the ER during maturation, and fuse with this or-
ganelle in a limited manner to acquire ER membranes.
Late BCVs Are ER-derived Organelles. To determine
whether BCVs harbor ER functional properties, we rea-
soned that the toxin aerolysin from Aeromonas hydrophila,
which vacuolates the ER (27), would also affect BCVs if
they have acquired ER properties. BMDM infected with
GFP Brucella for 36 h were left untreated or treated with
0.5 nM proaerolysin for 30 min before processing for im-
munofluorescence. In control macrophages, GFP Brucella
were scattered in the perinuclear region in calnexin  com-
partments (Fig. 6 A). By contrast, aerolysin treatment
caused a dramatic reorganization of bacteria, which gath-
ered inside calnexin  giant vacuoles (Fig. 6 B). Because
Brucella replicate in single bacterium-containing vacuoles in
untreated macrophages (Fig. 6 C), the effect of aerolysin
can be interpreted as triggering the fusion of individual
BCVs. To confirm this, we monitored the action of aero-
lysin during the treatment using EM. 10 min after toxin ad-
dition to the infected cells, a typical swelling of the ER was
observed (Fig. 6 D, arrows) and BCVs were found to fuse
with the ER (Fig. 6 D, arrowhead). After 30 min, BCVs
were fused together and covered with ribosomes, whereas
ER structures were no longer detected (Fig. 6 E), demon-
strating that aerolysin treatment had caused the fusion of
BCVs together and with the ER. Thus, these results show
that late BCVs not only harbor ER markers, but also dis-
play ER membrane properties, demonstrating that Brucella
replicate in an ER-derived organelle inside macrophages.
Figure 4. Some BCVs transiently harbor both LAMP-1 and calnexin.
BMDM were infected with the wild-type GFP Brucella for various times.
Samples were fixed and processed for immunofluorescence. Calnexin was
detected using rabbit anti–calnexin, followed by Alexa Fluor® 594–conju-
gated goat anti–rabbit antibodies. LAMP-1 was detected using a rat anti–
mouse LAMP-1 monoclonal antibody, followed by cyanin-5–conjugated
donkey anti–rat antibodies. (A) Quantitation of calnexin /LAMP-1 
( ), calnexin /LAMP-1  ( ), calnexin /LAMP-1  ( ), and calnexin /
LAMP-1  ( ) BCVs during a 24-h time course. BCVs were scored for
LAMP-1 and calnexin presence from single 0.2- m section images ob-
tained by confocal microscopy. (B) Details from single confocal image
sections showing representative BCVs at various times after infection. For
clarity, the images have been artificially recolored to show bacteria in
blue, LAMP-1 in green, and calnexin in red. Early BCVs (2 and 4 h after
infection) harbor both markers (arrowheads) whereas late (12 h after in-
fection) and replicative BCVs (24 h after infection) are only stained with
calnexin (arrowhead). Bar, 2  m.T
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Biogenesis of the Brucella Replicative Vacuole Does Not Re-
quire ER-Golgi COPI-dependent Vesicular Transport. The
intracellular pathogen L. pneumophila replicates within
macrophages in an ER-derived organelle (28). Recently,
Kagan and Roy (29) showed that biogenesis of the Le-
gionella replicative organelle depends upon ARF1/COPI-
dependent ER-Golgi vesicular transport, and Legionella in-
tracellular replication is inhibited when macrophages are
pretreated with BFA. To examine whether Brucella replica-
tion is also affected by the inhibition of ER-Golgi COPI-
dependent vesicular transport, BMDM were treated before
or at various times after infection with BFA and CFU were
enumerated at 1 and 24 h after infection. These treatments
did not exceed 3 h to avoid cytotoxicity. BFA pretreatment
did not impair Brucella uptake by macrophages, as deter-
mined by the number of intracellular bacteria at 1 h after
infection (Fig. 7 A). Unlike Legionella, BFA treatment 30
min before infection did not affect Brucella intracellular rep-
lication, nor did BFA treatments at 30 min, 2, 5, or 8 h af-
ter infection (Fig. 7 A). To exclude that BFA blocked bio-
genesis of the BCV, yet vacuolar maturation resumed after
the 3-h BFA treatments in a manner undetectable by CFU-
based assays, we compared the net increase in calnexin 
BCVs in untreated and BFA-treated macrophages over var-
ious time periods. Compared with untreated controls, BFA
treatment did not affect the rate of ER acquisition by
BCVs, either from 30 min to 4 h after infection (Fig. 7 B),
4 to 8 h after infection (Fig. 7 C), or 8 to 12 h after infec-
tion (Fig. 7 D). Thus, the biogenesis of the Brucella replica-
tive vacuole does not require ER-Golgi COPI-dependent
vesicular transport, which indicates that the mechanisms of
ER membrane acquisition by Brucella in macrophages are
different to that of Legionella.
Maturation of BCVs into an ER-derived Organelle Depends
upon a Functional VirB System. Our previous results (Fig.
1) suggested a role for VirB in BCV late maturation
events because the intracellular fate of wild-type and
virB10  Brucella diverged after 4 h after infection. To
clearly determine a role for VirB in BCV maturation in
BMDM, we examined the vacuole maturation of the sur-
viving GFP-expressing virB10 Brucella and compared their
interactions with the ER to those of the wild-type GFP-
2308. Using LAMP-1 as a marker of BCV maturation
(Fig. 2 C), we observed that the majority of vacuoles con-
taining either strain were LAMP-1  until 4 h after infec-
tion (Fig. 8, A and B). However, although the percentage
of LAMP-1  wild-type BCVs decreased after 4 h after in-
fection, vacuoles containing the virB10 mutant remained
positive (Fig. 8, A and B), as previously described in epi-
thelial cells (18). This indicates that virB mutants are defi-
cient in controlling vacuole maturation in BMDM after
4 h after infection.
Figure 5. BCVs acquire ER mem-
branes through limited fusion with the
ER. BMDM were infected with the
Brucella wild-type strain 2308 for vari-
ous times. Samples were processed for
conventional EM (A–D) or EM cy-
tochemistry for G6Pase detection (E–I).
(A) BCVs at 4 h after infection showing
a close contact with the ER (arrow). (B)
BCVs at 24 h after infection surrounded
by ER (arrows). (C) Enlarged view of
the vacuolar membrane from B show-
ing ribosomes studding the membrane
(arrowheads). (D) Enlarged view of the
contact site between ER and the vacu-
olar membrane showing ribosomes on
the vacuolar membrane (arrowhead).
(E) BCVs at 30 min after infection
showing no interaction with G6Pase 
ER. (F) BCVs at 2 h after infection in
close contact with G6Pase  ER (arrow-
heads). (G) BCVs at 4 h after infection
in intimate contact with several
G6Pase   ER compartments (arrow-
heads). (H) Representative G6Pase  late
BCVs at 24 h after infection (arrow-
heads show the intravacuolar G6Pase
reaction product). (I) G6Pase   late
BCVs at 24 h after infection. The right-
hand side BCV is fusing with the ER
(arrow). Bars, 1  m (A and B), 0.2  m
(C and D), and 0.5  m (E–I).T
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We also compared the interaction of the virB10 mutant
with ER structures using the translocator Sec61  as an ER
marker. Until 4 h after infection, both the wild-type and
virB10 mutant were surrounded by Sec61   structures
(Fig. 8 C) to a comparable level (Fig. 8 D). Indeed, vacu-
oles containing the virB10 mutant were found in intimate
contact with the ER (Fig. 8, E and F), like wild-type BCVs
(Fig. 5, F and G). Thus, the absence of a functional VirB
system does not prevent Brucella from initially contacting
the ER. However, after 4 h of infection, although the per-
centage of Sec61   wild-type BCVs continued to increase
(88.7   6.4% positive at 24 h after infection; Fig. 8 D), that
of the virB10 mutant–containing vacuoles stalled and then
decreased to 25.7   4.7% over the same time frame (Fig. 8
Figure 6. Late BCVs harbor ER properties.
BMDM were infected with the wild-type GFP
Brucella for 36 h, and then treated with 0.5 nM
proaerolysin or mock treated for 10 or 30 min be-
fore processing for either immunofluorescence (A
and B) or EM (C–E). (A) Confocal images of a
control untreated macrophage showing replicating
GFP  Brucella scattered around the nucleus in
calnexin  vacuoles (red). The inset shows individ-
ual bacteria within calnexin  vacuoles. (B) Confo-
cal images of an aerolysin-treated macrophage
showing a dramatic relocation of GFP Brucella into
giant calnexin  vacuoles. The inset shows multiple
bacteria enclosed within a large calnexin  vacuole.
(C) EM picture of an untreated macrophage show-
ing replicating Brucella in individual vacuoles. (D)
EM picture of an infected macrophage treated with
proaerolysin for 10 min. Typical aerolysin-induced
swelling of the ER is visible (arrows) and BCVs
start to fuse with the ER (arrowhead). (E) EM pic-
ture of an infected macrophage treated with
proaerolysin for 30 min. BCVs have fused together
(arrowheads) into a large compartment covered
with ribosomes (arrows). Bars, 10  m (A and B), 2
 m (insets in A and B), 1  m (C), and 0.5  m (D
and E).
Figure 7. Brucella intracellular replication does not require ER-Golgi COPI-dependent vesicular transport. (A) BMDM infected with the wild-type
Brucella strain 2308 were left untreated or treated with 10  g/ml BFA either 30 min before infection, or 30 min, 2, 5, or 8 h after infection, over a 3-h
period. For each treatment, CFUs were enumerated after 1 and 24 h after infection. Data are from a representative experiment (n   3 independent ex-
periments). (B–D) BMDM infected with the wild-type Brucella strain GFP-2308 were left untreated or treated with 10  g/ml BFA either from 30 min
to 4 h after infection (B), 4–8 h after infection (C), or 8–12 h after infection (D). Samples were processed for immunofluorescence staining and calnexin 
BCVs were scored. Data are means   SD of three independent experiments.T
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D). By EM, the few vacuoles containing intact bacteria we
observed by 8 h after infection were no longer associated
with the ER and no BCV–ER fusions were observed, as
assessed by lack of G6Pase staining of bacterial vacuoles
(Fig. 8 G). Hence, virB10 mutants are unable to control
ER membrane acquisition to their vacuole. As a conse-
quence, their compartment cannot mature into a replica-
tion-competent organelle and eventually fuses with lyso-
somes (Fig. 1). Taken together, these results demonstrate
that the VirB type IV secretion system of Brucella is re-
quired for late maturation events of the vacuole, which
correspond to the BCV–ER fusion necessary for the bio-
genesis of the Brucella ER-derived replicative vacuole.
Discussion
In this work, we have used an infection model of murine
BMDM and identified some key aspects of Brucella intracel-
lular survival and replication. We have shown that intracel-
lular replication of B. abortus occurs within single bacte-
rium-containing compartments segregated from the endocytic
pathway, which possess properties of the host cell ER (Fig.
9). Biogenesis of these organelles results from sustained in-
teractions and limited fusion with the ER that depends
upon a functional VirB type IV secretion system.
Given their significant amounts of active hydrolytic en-
zymes (23) and the large number of late endosomes/lyso-
somes (30), BMDM constitute an adequate model to
confront intracellular Brucella with highly bactericidal con-
ditions, in which absence of fusion with lysosomes is not
due to the scarcity of degradative organelles. Indeed, the
majority of phagocytosed Brucella are rapidly degraded
within BMDM. However, some bacteria do survive this
initial killing event and some eventually replicate intracel-
lularly. A mutant of the VirB type IV secretion system is
initially killed to the same extent as the wild-type strain, in-
dicating that Brucella initial survival is independent of VirB
(Fig. 9). Similar results have been reported in human
Figure 8. VirB mutant–containing vacuoles fail to sustain fusion-proficient interactions with the ER. BMDM were infected with either the wild-type
Brucella strain GFP-2308 or the mutant strain GFP-virB10 for various times. Samples were processed for immunofluorescence (A–D) or EM staining for
G6Pase (E–G). (A) Confocal images of infected BMDM showing acquisition of LAMP-1 on 2308 or virB10-containing vacuoles after 4 or 24 h of infec-
tion. (B) Quantitation of LAMP-1 acquisition by 2308 ( )- or virB10 ( )-containing vacuoles. Data are means   SD of three independent experiments.
(C) Confocal images of GFP Brucella–infected BMDM showing association with, or acquisition of, Sec61   structures on 2308 or virB10-containing vac-
uoles after 4 or 24 h of infection. (D) Quantitation of association of Sec61   structures with 2308 ( )- or virB10 ( )-containing vacuoles. Data are
means   SD of five independent experiments. (E) Staining for G6Pase in virB10-infected BMDM at 2 h after infection. The arrowhead shows a close
association of BCVs with ER. (F) Staining for G6Pase in virB10-infected BMDM at 4 h after infection. The BCV is surrounded by ER (arrowheads). (G)
Staining for G6Pase in virB10-infected BMDM at 8 h after infection Arrowheads show that the ER is no longer in the close vicinity of the BCV. G6Pase
reaction product is not detectable inside the BCV. Bars, 5  m (A and C), 1  m (insets in A and C), and 0.5  m (E–G).T
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monocytes, using a Brucella suis virB9 mutant (31). Re-
cently, Sun et al. (32) showed that the B. abortus VirB sys-
tem is not involved in evading inducible nitric oxide syn-
thase– or NADPH oxidase–mediated killing in vivo, which
is in agreement with our results. In our system, VirB was
only implicated in BCV trafficking events occurring after
4 h after infection, specifically the maturation events required
for long-term survival and replication (Fig. 9). This is con-
sistent with intracellular expression kinetics of the B. suis
virB operon in J774 cells (19). A VirB-defective mutant,
which cannot control BCV interactions with the ER, re-
mains in an intermediate, immature compartment that ulti-
mately fuses with lysosomes. Hence, the VirB-dependent
maturation of the BCV into an ER-derived replicative
compartment is essential to long-term survival and allows
the creation of a safe intracellular niche.
Our results (Figs. 2 and 9) exclude a late endosomal na-
ture for the Brucella replicative compartment in macro-
phages, as has been previously purported (7). Nonetheless,
BCVs transiently interact with early but not late compart-
ments of the endocytic pathway during intracellular
trafficking. Furthermore, the acquisition of the late en-
dosomal/lysosomal marker LAMP-1 suggests that BCVs
interact with some LAMP-1  compartments, either distinct
from late endocytic organelles, or a subset of compartments
devoid of CI-M6PR and cathepsin D. However, the ab-
sence of Rab7 recruitment, which controls fusion of late
endocytic organelles, excludes BCV interactions with late
endocytic compartments. Consistently, Brucella intracellular
trafficking in nonphagocytic cells is independent of Rab7
(33). The nature and role of LAMP-1  compartments in
Brucella intracellular trafficking remain to be determined.
These intermediate vacuoles likely mature into replicating
compartments because a significant fraction of them are ca-
pable of interactions with the ER. Considered together,
our results for BCV trafficking in BMDM are reminiscent
of that described in epithelial cells (9), suggesting that Bru-
cella uses similar mechanisms to control its intracellular sur-
vival and replication in diverse host cell types.
By replicating inside an ER-derived organelle in mac-
rophages, Brucella displays an intracellular fate similar to that
of Legionella (28). Biogenesis of Legionella-replicative com-
partments depends upon a rapid interception of COPI-
dependent vesicular trafficking from endoplasmic ER exit
sites, a process that can be blocked by BFA (29). In con-
trast, BFA did not have any inhibitory effect on Brucella in-
tracellular replication, nor did it affect the rate of ER
marker acquisition by BCVs, highlighting mechanistic dif-
ferences between the maturation processes of these two
replicative organelles. Indeed, we did not detect any dock-
ing of ribosome-lined, ER-derived vesicles on early BCVs,
as is the case for the Legionella phagosome (34), but BCVs
were shown to dock with the ER at later time points. Ex-
tensive Brucella replication at late time points is accompa-
nied by a dramatic and nearly complete recruitment of ER
to dividing BCVs. This indicates that the BCV–ER inter-
actions are prolonged during bacterial replication and illus-
trates how important these interactions are for Brucella in-
tracellular survival within macrophages. Altogether, these
results clearly indicate that biogenesis mechanisms of the
Brucella replicative organelle similarly involve the ER in
both phagocytic and nonphagocytic cells, thus precluding
previous interpretations on the differential maturation and
nature of the BCVs in phagocytic versus nonphagocytic
cells (7, 35).
How Brucella recruit and interact with the ER remains to
be elucidated. Organelle membrane fusion after transport
vesicle targeting is a complex multistage process that can be
divided into (a) an initial loose or distant interaction of the
vesicle with the target compartment, called tethering, and
(b) a more intimate contact or docking, which leads to
membrane fusion (36, 37). The initial tethering, which in-
volves specific tethering molecules and Rab GTPases, is
not sufficient for fusion (36). Subsequent docking and fu-
sion events require proteins of the SNARE family (38). We
have shown that BCVs contact ER structures in a VirB-
independent manner, whereas the fusion-proficient, sus-
tained interactions are dependent upon a functional VirB
system. It is possible that the initial BCV–ER contact con-
sists of a tethering of the BCV to the ER, or reciprocally,
which is not sufficient for fusion. The subsequent fusion-
proficient interactions would correspond to docking and
Figure 9. Model for Brucella evasion of macrophage killing. After en-
try, intracellular Brucella resides within a vacuole (BCV) that interacts
with early endosomes. These early BCVs avoid further interactions with
the endocytic pathway, yet acquire LAMP-1 and are found surrounded
by, or in close contact with, the ER within the first hours after infection
(A). Such interactions are sustained over time and lead to limited fusion
events (B), ultimately generating an ER-derived organelle permissive for
Brucella replication (C). Vacuoles containing a virB-defective mutant fail
to sustain fusion-proficient interactions with the ER (D) and ultimately
fuse with lysosomes (E). The shaded area designates the VirB-dependent
maturation events of BCVs described in this work. ER membrane acqui-
sition by BCVs is illustrated by the localized presence of ribosomes.T
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fusion events, mediated by the action of the VirB type IV
secretion system. We speculate that these docking and fu-
sion events are controlled by a bacterial effector(s) translo-
cated into the host cell or the vacuolar membrane.
In conclusion, we propose a model of the Brucella repli-
cative organelle biogenesis through subversion of the mac-
rophage ER (Fig. 9). Rapidly after entry, Brucella escape
the endocytic pathway to be located in an intermediate,
nonreplicative compartment, which is able to interact with
the ER, possibly through tethering activities. Subsequent
VirB-dependent maturation of BCVs consists of sustained,
fusion-proficient interactions with the ER, which lead to
ER membrane accretion by BCVs, to a stage where they
acquire functional properties of this compartment. ER-
derived organelles support Brucella replication in individual
vacuoles through continual ER membrane accretion to
provide the new input of membrane required during bac-
terial growth and division. Future studies are aimed at
identifying the bacterial and host cell factors involved in
these processes.
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